Intensive care and anesthesia management for HARPOON beating heart mitral valve repair
- PMID: 32687090
- PMCID: PMC7559944
- DOI: 10.4103/aca.ACA_200_18
Intensive care and anesthesia management for HARPOON beating heart mitral valve repair
Erratum in
-
Erratum: Intensive care and anesthesia management for HARPOON beating heart mitral valve repair.Ann Card Anaesth. 2020 Oct-Dec;23(4):545. doi: 10.4103/0971-9784.298546. Ann Card Anaesth. 2020. PMID: 33109829 Free PMC article.
Abstract
Patients with severe mitral valve regurgitation secondary to degenerative disease are known to benefit from mitral valve repair surgery. Novel techniques for achieving mitral valve repair on the beating heart have been developed and are being introduced into clinical practice. The HARPOON Beating Heart Mitral Valve Repair System (MVRS) in recent studies has demonstrated efficacy and safety for the repair of degenerative mitral valve disease on the beating heart. The device uses transoesophageal echocardiographic guidance to implant artificial expanded polytetrafluoroethylene (ePTFE) cords on prolapsed mitral valve leaflets in the beating heart. It requires general anaesthesia and there are specific intensive care and anaesthesia considerations for the safe management of these cases. This article describes the general principles of intensive care and anaesthesia management employed for the initial patients treated with the HARPOON Beating Heart MVRS, the outcomes for these patients, and the potential challenges for the future management of these cases.
Keywords: Cardiovascular anaesthesia and surgery; catheter-based coronary and valvular interventions; image guidance; mitral valve repair; transesophageal echocardiography; valvular heart disease.
Conflict of interest statement
None
Figures



References
-
- Falk V, Seeburger J, Czesla M, Borger MA, Willinge J, Kuntze T, et al. How does the use of polytetrafluoroethylene neocordae for posterior mitral valve prolapse (loop technique) compare with leaflet resection? A prospective randomized trial. J Thorac Cardiovasc Surg. 2008;136:1200–6. - PubMed
-
- David TE, Armstrong S, Ivanov J. Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25-year experience. J Thorac Cardiovasc Surg. 2013;145:1563–9. - PubMed
-
- Vetter HO, Burack JH, Factor SM. Replacement of chordae tendineae using new expanded PTFE suture in sheep. In: Bodnar E, Yacoub M, editors. Biologic and Bioprosthetic Valves. New York: Medical Books; 1986. pp. 772–80.
-
- Feldman T, Wasserman HS, Herrmann HC, Gray W, Block PC, Whitlow P, et al. Percutaneous mitral valve repair using the edge-to-edge technique: Six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol. 2005;46:2134–40. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical